These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
776 related articles for article (PubMed ID: 26976734)
1. FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. McIntosh K; Reed DE; Schneider T; Dang F; Keshteli AH; De Palma G; Madsen K; Bercik P; Vanner S Gut; 2017 Jul; 66(7):1241-1251. PubMed ID: 26976734 [TBL] [Abstract][Full Text] [Related]
2. A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial. Staudacher HM; Lomer MCE; Farquharson FM; Louis P; Fava F; Franciosi E; Scholz M; Tuohy KM; Lindsay JO; Irving PM; Whelan K Gastroenterology; 2017 Oct; 153(4):936-947. PubMed ID: 28625832 [TBL] [Abstract][Full Text] [Related]
3. Low FODMAP diet reduces gastrointestinal symptoms in irritable bowel syndrome and clinical response could be predicted by symptom severity: A randomized crossover trial. Algera JP; Demir D; Törnblom H; Nybacka S; Simrén M; Störsrud S Clin Nutr; 2022 Dec; 41(12):2792-2800. PubMed ID: 36384081 [TBL] [Abstract][Full Text] [Related]
4. Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs. Bennet SMP; Böhn L; Störsrud S; Liljebo T; Collin L; Lindfors P; Törnblom H; Öhman L; Simrén M Gut; 2018 May; 67(5):872-881. PubMed ID: 28416515 [TBL] [Abstract][Full Text] [Related]
5. Microbiome-driven IBS metabotypes influence response to the low FODMAP diet: insights from the faecal volatome. Conley TE; Slater R; Moss S; Bulmer DC; Negro JR; Ijaz UZ; Pritchard DM; Parkes M; Probert C EBioMedicine; 2024 Sep; 107():105282. PubMed ID: 39173527 [TBL] [Abstract][Full Text] [Related]
6. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Halmos EP; Power VA; Shepherd SJ; Gibson PR; Muir JG Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059 [TBL] [Abstract][Full Text] [Related]
7. A low FODMAP diet plus traditional dietary advice versus a low-carbohydrate diet versus pharmacological treatment in irritable bowel syndrome (CARIBS): a single-centre, single-blind, randomised controlled trial. Nybacka S; Törnblom H; Josefsson A; Hreinsson JP; Böhn L; Frändemark Å; Weznaver C; Störsrud S; Simrén M Lancet Gastroenterol Hepatol; 2024 Jun; 9(6):507-520. PubMed ID: 38643782 [TBL] [Abstract][Full Text] [Related]
8. Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs. Harvie RM; Chisholm AW; Bisanz JE; Burton JP; Herbison P; Schultz K; Schultz M World J Gastroenterol; 2017 Jul; 23(25):4632-4643. PubMed ID: 28740352 [TBL] [Abstract][Full Text] [Related]
9. Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: A meta-analysis of clinical studies. Varjú P; Farkas N; Hegyi P; Garami A; Szabó I; Illés A; Solymár M; Vincze Á; Balaskó M; Pár G; Bajor J; Szűcs Á; Huszár O; Pécsi D; Czimmer J PLoS One; 2017; 12(8):e0182942. PubMed ID: 28806407 [TBL] [Abstract][Full Text] [Related]
10. Randomised clinical trial: low-FODMAP rye bread vs. regular rye bread to relieve the symptoms of irritable bowel syndrome. Laatikainen R; Koskenpato J; Hongisto SM; Loponen J; Poussa T; Hillilä M; Korpela R Aliment Pharmacol Ther; 2016 Sep; 44(5):460-70. PubMed ID: 27417338 [TBL] [Abstract][Full Text] [Related]
11. IBS randomized study: FODMAPs alter bile acids, phenolic- and tryptophan metabolites, while gluten modifies lipids. Nordin E; Hellström PM; Vuong E; Ribbenstedt A; Brunius C; Landberg R Am J Physiol Regul Integr Comp Physiol; 2023 Sep; 325(3):R248-R259. PubMed ID: 37399002 [TBL] [Abstract][Full Text] [Related]
12. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Böhn L; Störsrud S; Liljebo T; Collin L; Lindfors P; Törnblom H; Simrén M Gastroenterology; 2015 Nov; 149(6):1399-1407.e2. PubMed ID: 26255043 [TBL] [Abstract][Full Text] [Related]
13. Low fermentable oligo-di-mono-saccharides and polyols diet versus general dietary advice in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial. Zahedi MJ; Behrouz V; Azimi M J Gastroenterol Hepatol; 2018 Jun; 33(6):1192-1199. PubMed ID: 29159993 [TBL] [Abstract][Full Text] [Related]
14. Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial. Cox SR; Lindsay JO; Fromentin S; Stagg AJ; McCarthy NE; Galleron N; Ibraim SB; Roume H; Levenez F; Pons N; Maziers N; Lomer MC; Ehrlich SD; Irving PM; Whelan K Gastroenterology; 2020 Jan; 158(1):176-188.e7. PubMed ID: 31586453 [TBL] [Abstract][Full Text] [Related]
15. Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Halmos EP; Christophersen CT; Bird AR; Shepherd SJ; Gibson PR; Muir JG Gut; 2015 Jan; 64(1):93-100. PubMed ID: 25016597 [TBL] [Abstract][Full Text] [Related]
16. Fermentable oligo-, di-, monosaccharides, and polyols (FODMAPs), but not gluten, elicit modest symptoms of irritable bowel syndrome: a double-blind, placebo-controlled, randomized three-way crossover trial. Nordin E; Brunius C; Landberg R; Hellström PM Am J Clin Nutr; 2022 Feb; 115(2):344-352. PubMed ID: 34617561 [TBL] [Abstract][Full Text] [Related]
17. Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial. Yan R; Murphy M; Genoni A; Marlow E; Dunican IC; Lo J; Andrew L; Devine A; Christophersen CT BMJ Open Gastroenterol; 2020 Aug; 7(1):. PubMed ID: 32816830 [TBL] [Abstract][Full Text] [Related]
18. A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D. Eswaran SL; Chey WD; Han-Markey T; Ball S; Jackson K Am J Gastroenterol; 2016 Dec; 111(12):1824-1832. PubMed ID: 27725652 [TBL] [Abstract][Full Text] [Related]
19. Fecal Fermentation in Irritable Bowel Syndrome: Influence of Dietary Restriction of Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols. Valeur J; Røseth AG; Knudsen T; Malmstrøm GH; Fiennes JT; Midtvedt T; Berstad A Digestion; 2016; 94(1):50-6. PubMed ID: 27487397 [TBL] [Abstract][Full Text] [Related]
20. Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome. Hustoft TN; Hausken T; Ystad SO; Valeur J; Brokstad K; Hatlebakk JG; Lied GA Neurogastroenterol Motil; 2017 Apr; 29(4):. PubMed ID: 27747984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]